These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9403661)

  • 1. Discontinuation of long-term transfusion therapy in patients with sickle cell disease and stroke.
    Rana S; Houston PE; Surana N; Shalaby-Rana EI; Castro OL
    J Pediatr; 1997 Nov; 131(5):757-60. PubMed ID: 9403661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High risk of recurrent stroke after discontinuance of five to twelve years of transfusion therapy in patients with sickle cell disease.
    Wang WC; Kovnar EH; Tonkin IL; Mulhern RK; Langston JW; Day SW; Schell MJ; Wilimas JA
    J Pediatr; 1991 Mar; 118(3):377-82. PubMed ID: 1999776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography.
    Adams RJ; McKie VC; Hsu L; Files B; Vichinsky E; Pegelow C; Abboud M; Gallagher D; Kutlar A; Nichols FT; Bonds DR; Brambilla D
    N Engl J Med; 1998 Jul; 339(1):5-11. PubMed ID: 9647873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia.
    DeBaun MR; Gordon M; McKinstry RC; Noetzel MJ; White DA; Sarnaik SA; Meier ER; Howard TH; Majumdar S; Inusa BP; Telfer PT; Kirby-Allen M; McCavit TL; Kamdem A; Airewele G; Woods GM; Berman B; Panepinto JA; Fuh BR; Kwiatkowski JL; King AA; Fixler JM; Rhodes MM; Thompson AA; Heiny ME; Redding-Lallinger RC; Kirkham FJ; Dixon N; Gonzalez CE; Kalinyak KA; Quinn CT; Strouse JJ; Miller JP; Lehmann H; Kraut MA; Ball WS; Hirtz D; Casella JF
    N Engl J Med; 2014 Aug; 371(8):699-710. PubMed ID: 25140956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Splenectomy to Optimize Hemoglobin S Control in Children With Sickle Cell Anemia on Chronic Transfusion Therapy for Stroke Prevention.
    Black LV; Ramesar JS; Boston CH
    J Pediatr Hematol Oncol; 2019 Mar; 41(2):158-160. PubMed ID: 29668544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions.
    Pegelow CH; Adams RJ; McKie V; Abboud M; Berman B; Miller ST; Olivieri N; Vichinsky E; Wang W; Brambilla D
    J Pediatr; 1995 Jun; 126(6):896-9. PubMed ID: 7776091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Periodic transfusions for sickle cell anemia and CNS infarction.
    Sarnaik S; Soorya D; Kim J; Ravindranath Y; Lusher J
    Am J Dis Child; 1979 Dec; 133(12):1254-7. PubMed ID: 517476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease.
    Adams RJ; Brambilla D;
    N Engl J Med; 2005 Dec; 353(26):2769-78. PubMed ID: 16382063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A modified transfusion program for prevention of stroke in sickle cell disease.
    Cohen AR; Martin MB; Silber JH; Kim HC; Ohene-Frempong K; Schwartz E
    Blood; 1992 Apr; 79(7):1657-61. PubMed ID: 1558963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility and efficacy of chronic transfusion for stroke prevention in children with sickle cell disease.
    Mirre E; Brousse V; Berteloot L; Lambot-Juhan K; Verlhac S; Boulat C; Dumont MD; Lenoir G; de Montalembert M
    Eur J Haematol; 2010 Mar; 84(3):259-65. PubMed ID: 19912310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood transfusion therapy is feasible in a clinical trial setting in children with sickle cell disease and silent cerebral infarcts.
    King AA; Noetzel M; White DA; McKinstry RC; Debaun MR
    Pediatr Blood Cancer; 2008 Mar; 50(3):599-602. PubMed ID: 17985350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exchange blood transfusion compared with simple transfusion for first overt stroke is associated with a lower risk of subsequent stroke: a retrospective cohort study of 137 children with sickle cell anemia.
    Hulbert ML; Scothorn DJ; Panepinto JA; Scott JP; Buchanan GR; Sarnaik S; Fallon R; Chu JY; Wang W; Casella JF; Resar L; Berman B; Adamkiewicz T; Hsu LL; Smith-Whitley K; Mahoney D; Woods G; Watanabe M; DeBaun MR
    J Pediatr; 2006 Nov; 149(5):710-2. PubMed ID: 17095350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term results using hydroxyurea/phlebotomy for reducing secondary stroke risk in children with sickle cell anemia and iron overload.
    Greenway A; Ware RE; Thornburg CD
    Am J Hematol; 2011 Apr; 86(4):357-61. PubMed ID: 21442640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of chronic transfusion on incidence of pain and acute chest syndrome during the Stroke Prevention Trial (STOP) in sickle-cell anemia.
    Miller ST; Wright E; Abboud M; Berman B; Files B; Scher CD; Styles L; Adams RJ;
    J Pediatr; 2001 Dec; 139(6):785-9. PubMed ID: 11743502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fulminant stroke in an adult patient with sickle cell anemia.
    Vicari P; Sampaio Silva G; de Cassia Rosário Cavalheiro R; Massaro AR; Figueiredo MS
    Acta Haematol; 2006; 116(1):67-9. PubMed ID: 16809893
    [No Abstract]   [Full Text] [Related]  

  • 16. Pathologic quiz case: a 16-year-old adolescent girl with a trace level of hemoglobin s detected by high-performance liquid chromatography. Almost complete suppression of hemoglobin S in a sickle cell disease patient undergoing long-term transfusion therapy.
    Scurlock D; Risin SA
    Arch Pathol Lab Med; 2005 Apr; 129(4):e107-8. PubMed ID: 15794693
    [No Abstract]   [Full Text] [Related]  

  • 17. Increased complications of chronic erythrocytapheresis compared with manual exchange transfusions in children and adolescents with sickle cell disease.
    Woods D; Hayashi RJ; Binkley MM; Sparks GW; Hulbert ML
    Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28544309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Less intensive long-term transfusion therapy for sickle cell anemia and cerebrovascular accident.
    Miller ST; Jensen D; Rao SP
    J Pediatr; 1992 Jan; 120(1):54-7. PubMed ID: 1731025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Etiology of strokes in children with sickle cell anemia.
    Debaun MR; Derdeyn CP; McKinstry RC
    Ment Retard Dev Disabil Res Rev; 2006; 12(3):192-9. PubMed ID: 17061288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke.
    Scothorn DJ; Price C; Schwartz D; Terrill C; Buchanan GR; Shurney W; Sarniak I; Fallon R; Chu JY; Pegelow CH; Wang W; Casella JF; Resar LS; Berman B; Adamkiewicz T; Hsu LL; Ohene-Frempong K; Smith-Whitley K; Mahoney D; Scott JP; Woods GM; Watanabe M; Debaun MR
    J Pediatr; 2002 Mar; 140(3):348-54. PubMed ID: 11953734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.